Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs
Authors:
- Eustachio NettisEustachio Nettis
- Roberto Di PaolaRPRoberto Di Paola
- Antonio FerranniniAFAntonio Ferrannini
- Alfredo TursiATAlfredo Tursi
- 1 March 2002
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (3) , 331-334
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactionsAnnals of Allergy, Asthma & Immunology, 2001
- Meloxicam in hypersensitivity to NSAIDsAllergy, 2001
- Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthmaJournal of Allergy and Clinical Immunology, 2001
- Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugsAnnals of Allergy, Asthma & Immunology, 2000
- Approach to the Patient with a History of Adverse Reactions to Aspirin or NSAIDs: Diagnosis and TreatmentAllergy and Asthma Proceedings, 2000
- Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regionsBritish Journal of Clinical Pharmacology, 1999
- Aspirin-induced asthma: Advances in pathogenesis and managementJournal of Allergy and Clinical Immunology, 1999
- COX-2 inhibitorsThe Lancet, 1999
- Floctafenine: a Valid Alternative in Patients with Adverse Reactions to Nonsteroidal Anti-inflammatory DrugsAnnals of Allergy, Asthma & Immunology, 1997
- A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymesTrends in Pharmacological Sciences, 1997